We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+7.17%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
AUM
$9.48B
AUM Growth
+$390M
Cap. Flow
-$132M
Cap. Flow %
-1.39%
Top 10 Hldgs %
11.25%
Holding
369
New
30
Increased
62
Reduced
248
Closed
25

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$66.1M
2
ICE icon
Intercontinental Exchange
ICE
+$52.6M
3
VZ icon
Verizon
VZ
+$42M
4
WLK icon
Westlake Corp
WLK
+$38M
5
SNBR
Sleep Number
SNBR
+$31.9M

Sector Composition

Rank Sector Weight
1 Financials 19.71%
2 Industrials 15.82%
3 Healthcare 13.9%
4 Technology 12.06%
5 Consumer Discretionary 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAT
326
DELISTED
BioTelemetry, Inc.
BEAT
$1.63M 0.02%
54,350
-4,096
-7% -$119K
ADC icon
327
Agree Realty
ADC
$8.76B
$1.5M 0.02%
29,111
-1,656
-5% -$82.1K
JBLU icon
328
JetBlue
JBLU
$1.61B
$1.44M 0.02%
64,371
ESPR
329
DELISTED
Esperion Therapeutics
ESPR
$1.37M 0.01%
20,871
-1,554
-7% -$83.7K
HVT icon
330
Haverty Furniture Companies
HVT
$429M
$1.37M 0.01%
60,652
-3,422
-5% -$82.4K
UEIC icon
331
Universal Electronics
UEIC
$62.2M
$1.33M 0.01%
28,256
-2,113
-7% -$117K
FOLD
332
DELISTED
Amicus Therapeutics
FOLD
$1.33M 0.01%
+92,509
New +$1.27M
NNN icon
333
NNN REIT
NNN
$8.34B
$1.24M 0.01%
28,713
RARE icon
334
Ultragenyx Pharmaceutical
RARE
$1.31B
$1.17M 0.01%
25,176
-1,883
-7% -$92.3K
ACRS icon
335
Aclaris Therapeutics
ACRS
$804M
$1.14M 0.01%
46,289
-3,494
-7% -$85.1K
RGA icon
336
Reinsurance Group of America
RGA
$16.1B
$1.11M 0.01%
7,109
-1,903
-21% -$288K
FANG icon
337
Diamondback Energy
FANG
$58.9B
$841K 0.01%
6,660
IWD icon
338
iShares Russell 1000 Value ETF
IWD
$82.6B
$760K 0.01%
+6,109
New +$740K
STE icon
339
Steris
STE
$20.7B
$655K 0.01%
+7,489
New +$668K
BDX icon
340
Becton Dickinson
BDX
$49.7B
$610K 0.01%
2,921
-99
-3% -$20.7K
BNY
341
Bank of New York Mellon
BNY
$105B
$599K 0.01%
11,116
-423
-4% -$22.5K
ZTS icon
342
Zoetis
ZTS
$30.3B
$375K ﹤0.01%
5,206
-1,083
-17% -$74.4K
BMY icon
343
Bristol-Myers Squibb
BMY
$130B
$370K ﹤0.01%
6,036
VLO icon
344
Valero Energy
VLO
$111B
$360K ﹤0.01%
3,916
-164,921
-98% -$13.6M
A icon
345
Agilent Technologies
A
$41.9B
-8,652
Closed -$555K
ABT icon
346
Abbott
ABT
$176B
-7,556
Closed -$403K
AEO icon
347
American Eagle Outfitters
AEO
$2.49B
-219,958
Closed -$3.15M
ALK icon
348
Alaska Air
ALK
$4.44B
-105,400
Closed -$8.04M
AX icon
349
Axos Financial
AX
$5.31B
-59,586
Closed -$1.7M
BAH icon
350
Booz Allen Hamilton
BAH
$9.37B
-370,267
Closed -$13.8M

Similar funds

Rothschild & Co Asset Management US's Q4 2017 Portfolio in Review

As of Q4 2017, Rothschild & Co Asset Management US held 369 positions worth $9.48B, up 4.3% from $9.09B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Rothschild & Co Asset Management US's Q4 2017 filing shows 30 new, 62 increased, 248 reduced and 25 closed positions. Its largest new stake was Intercontinental Exchange: 766,622 shares worth $54.1M. The largest sale was Edison International, an estimated $43M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Rothschild & Co Asset Management US's largest Q4 2017 buy was Intercontinental Exchange: 766,622 shares worth $54.1M.
  • Rothschild & Co Asset Management US added most to AbbVie in Q4 2017, an estimated $66.1M increase.
  • Rothschild & Co Asset Management US's biggest Q4 2017 reduction was Broadcom, cutting an estimated $28M.
  • Rothschild & Co Asset Management US fully exited Edison International in Q4 2017, selling an estimated $43M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 11% of its $9.48B portfolio in Q4 2017.
  • Rothschild & Co Asset Management US opened 30 new positions and closed 25 in Q4 2017.
  • Rothschild & Co Asset Management US's portfolio value rose 4.3% quarter-over-quarter to $9.48B.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2017, filed 12 Feb 2018.